Unresectable Locally Advanced or Metastatic, Medullary Thyroid Carcinoma
1 clinical trials · Condition
◉ Watch Unresectable Locally Advanced or Metastatic, Medullary Thyroid Carcinoma
| Record | Firm | Date |
|---|---|---|
| Evaluate the Safety and Tolerability of Vandetanib in Japanese Patients With Medullary Thyroid Carcinoma (NCT01661179) | Genzyme, a Sanofi Company | 2012-11-01 |
Track Unresectable Locally Advanced or Metastatic, Medullary Thyroid Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.